ADVANCED HEALTHCARE

Case Study #4:
New Metabolic Profiling Research

If ultra-early diagnosis with minimal stress on the body can be achieved, then an increase
in life expectancy will likely result. We intend to conduct research aimed at achieving
methods that are less invasive and more informative.

Early Screening Methods for Colon Cancer(Kobe University and Shimadzu Corporation)

Multi-biomarkers that can be used for diagnosing colon cancer were discovered from metabolomic analysis. The diagnostic predictive algorithms created based on those research-use-only biomarkers have been shown to maintain high sensitivity, even for early-stage colon cancer patients. The ability to measure the biomarkers with minimally invasive blood tests means there is hope for the possibility of screening patients in a clinic, for example, without the effects of bleeding during examinations.
Note: These measures are still currently in research and development.
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.

New Technologies for Advanced Cancer Detection (University of Yamanashi and Shimadzu Corporation)

Currently, pathological diagnoses involve acquiring a localized sample, preparing a specimen, observing the specimen under a microscope, and then making a diagnosis. That process requires about 30 minutes. In addition to being time-consuming, it requires significant technical skill by the pathologist. Recently, we developed a new probe electrospray ionization (PESI) technology for mass spectrometry (MS) that enables analyzing data acquired from trace tissue samples. It is the basis for a rapid pathological diagnosis support system (PESI-MS), currently in development, that can complete the measurement process in about two minutes after local sampling.
Note: These measures are still currently in research and development.
FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC PROCEDURES.